Acceleron Pharma (XLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | XLRN | INCY | EXAS | ||
| Company | Acceleron Pharma | Incyte Corp | Exact Sciences Cor | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 179.85 | 51.75 | 59.46 | ||
| High | 179.85 | 53.27 | 60.33 | ||
| Low | 177.06 | 51.71 | 58.62 | ||
| Last | 178.75 | 52.55 | 58.78 | ||
| Change | -0.93 | +0.87 | -0.07 | ||
| % Change | -0.52% | +1.68% | -0.12% | ||
| Volume | 7,884,200 | 2,342,920 | 1,669,100 | ||
| 20-Day Average Volume | 1,302,050 | 1,732,733 | 2,985,190 | ||
| Previous Close | 179.68 | 51.68 | 58.85 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 174.46 | 53.54 | 66.66 | ||
| 20-Day Raw Stochastic | 84.01% | 32.80% | 2.99% | ||
| 20-Day Relative Strength | 70.12% | 36.92% | 40.66% | ||
| Weighted Alpha | +57.78 | -21.72 | -19.40 | ||
| Today's Opinion | 100% Buy | 100% Sell | 72% Sell | ||
| Previous Opinion | 100% Buy | 100% Sell | 72% Sell | ||
| Last Month's Opinion | 88% Buy | 72% Sell | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.26% since 11/12/21 | +1.27% since 04/22/24 | -5.41% since 04/22/24 | ||
| Low | 173.17 on 11/16/21 | 50.35 on 04/25/24 | 58.40 on 04/25/24 | ||
| High | 179.94 on 11/17/21 | 53.27 on 04/29/24 | 65.00 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | +2.88% since 10/19/21 | -7.71% since 03/28/24 | -14.52% since 03/28/24 | ||
| Low | 172.25 on 10/20/21 | 50.35 on 04/25/24 | 58.40 on 04/25/24 | ||
| High | 179.94 on 11/17/21 | 57.15 on 04/02/24 | 79.62 on 04/02/24 | ||
| 3-Month | |||||
| %Chg | +48.97% since 08/19/21 | -13.05% since 01/29/24 | -11.70% since 01/29/24 | ||
| Low | 120.20 on 08/20/21 | 50.35 on 04/25/24 | 56.05 on 02/28/24 | ||
| High | 189.99 on 09/29/21 | 61.87 on 02/23/24 | 79.62 on 04/02/24 | ||
| 6-Month | |||||
| %Chg | +44.53% since 05/19/21 | +0.08% since 10/27/23 | -1.15% since 10/27/23 | ||
| Low | 113.49 on 07/15/21 | 50.27 on 10/31/23 | 56.05 on 02/28/24 | ||
| High | 189.99 on 09/29/21 | 67.36 on 01/04/24 | 79.62 on 04/02/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,931,634 | 11,603,504 | 10,683,100 | ||
| Shares Outstanding, K | 61,156 | 224,526 | 181,531 | ||
| Annual Sales | 92,520,000 | 3,695,650,000 | 2,499,770,000 | ||
| Annual Net Income | -166,030,000 | 597,600,000 | -204,150,000 | ||
| Last Quarter Sales | 34,200,000 | 1,013,340,000 | 646,890,000 | ||
| Last Quarter Net Income | -70,470,000 | 201,080,000 | -49,770,000 | ||
| 60-Month Beta | 0.13 | 0.65 | 1.25 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.16 on 11/04/21 | 1.06 on 02/13/24 | -0.27 on 02/21/24 | ||
| Latest Earnings Date | 11/04/21 | 04/30/24 | 05/08/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.10 | 0.00 | ||